NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+11.92%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.09B
AUM Growth
+$1.09B
(+13%)
Cap. Flow
+$78.5M
Cap. Flow
% of AUM
7.21%
Top 10 Holdings %
Top 10 Hldgs %
17.76%
Holding
259
New
59
Increased
62
Reduced
48
Closed
32
Top Buys
| 1 |
Broadcom
AVGO
|
$10.5M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$8.9M |
| 3 |
Boot Barn
BOOT
|
$7.46M |
| 4 |
SPS Commerce
SPSC
|
$7.13M |
| 5 |
Kornit Digital
KRNT
|
$6.95M |
Top Sells
| 1 |
Monolithic Power Systems
MPWR
|
$16.9M |
| 2 |
Crane NXT
CXT
|
$13.8M |
| 3 |
NVIDIA
NVDA
|
$6.11M |
| 4 |
Weatherford International
WFRD
|
$5.75M |
| 5 |
Advanced Micro Devices
AMD
|
$5.56M |
Sector Composition
| 1 | Industrials | 21.1% |
| 2 | Technology | 20.43% |
| 3 | Healthcare | 16.49% |
| 4 | Financials | 11.58% |
| 5 | Consumer Discretionary | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Biotechnology ETF
IBB
$5.6B
| $3.78M | 0.35% | +25,939 | New | +$3.78M |
|
102
TPG
TPG
$8.91B
| $3.74M | 0.34% | +64,986 | New | +$3.74M |
|
103
RxSight
RXST
$370M
| $3.67M | 0.34% | 74,347 -69,424 | -48% | -$3.43M |
|
104
Alphabet (Google) Class C
GOOG
$2.58T
| $3.65M | 0.33% | 21,818 +594 | +3% | +$99.3K |
|
105
Vertiv
VRT
$48.7B
| $3.61M | 0.33% | 36,259 +16,950 | +88% | +$1.69M |
|
106
Dick's Sporting Goods
DKS
$17B
| $3.57M | 0.33% | +17,125 | New | +$3.57M |
|
107
Southwest Airlines
LUV
$17.3B
| $3.56M | 0.33% | 120,089 +102,474 | +582% | +$3.04M |
|
108
Rocket Companies
RKT
$37.4B
| $3.54M | 0.32% | +184,406 | New | +$3.54M |
|
109
Invesco QQQ Trust
QQQ
$364B
| $3.48M | 0.32% | +7,123 | New | +$3.48M |
|
110
Krystal Biotech
KRYS
$4.27B
| $3.42M | 0.31% | 18,807 +1,480 | +9% | +$269K |
|
111
Vera Therapeutics
VERA
$1.38B
| $3.16M | 0.29% | 71,559 +12,430 | +21% | +$549K |
|
112
Harrow
HROW
$1.44B
| $3.12M | 0.29% | +69,477 | New | +$3.12M |
|
113
Arcellx
ACLX
$3.85B
| $3.06M | 0.28% | +36,586 | New | +$3.06M |
|
114
Klaviyo
KVYO
$9.73B
| $3.04M | 0.28% | +86,046 | New | +$3.04M |
|
|
BCAX
115
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $2.99M | 0.27% | +117,523 | New | +$2.99M |
|
116
GeneDx Holdings
WGS
$3.72B
| $2.94M | 0.27% | +69,337 | New | +$2.94M |
|
117
ARS Pharmaceuticals
SPRY
$1.15B
| $2.93M | 0.27% | +201,771 | New | +$2.93M |
|
118
Revolution Medicines
RVMD
$7.1B
| $2.83M | 0.26% | 62,300 -95,832 | -61% | -$4.35M |
|
119
Astrana Health
ASTH
$1.48B
| $2.79M | 0.26% | +48,131 | New | +$2.79M |
|
120
Axogen
AXGN
$743M
| $2.76M | 0.25% | +197,135 | New | +$2.76M |
|
121
Glaukos
GKOS
$5.5B
| $2.7M | 0.25% | +20,724 | New | +$2.7M |
|
122
Relay Therapeutics
RLAY
$619M
| $2.66M | 0.24% | +376,014 | New | +$2.66M |
|
123
Uber
UBER
$196B
| $2.66M | 0.24% | 35,332 -34,600 | -49% | -$2.6M |
|
124
ArcBest
ARCB
$1.68B
| $2.64M | 0.24% | 24,352 -37,755 | -61% | -$4.09M |
|
125
Nova
NVMI
$7.74B
| $2.61M | 0.24% | +12,523 | New | +$2.61M |
|